slides · global inventory
16 David Goliath
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 249
Current window 211-240
Pages 9
Rows per page 30
Loop
211-240 of 249
14
Eutelsat | Mergers and Acquisitions Presentation Deck | 32 slidesEutelsat | Mergers and Acquisitions Presentation Deck | 32 slides · Eutelsat
Conference presentation Investment bank Beat · SolutionLoop · David Goliath1 hit
15
Eutelsat | Mergers and Acquisitions Presentation Deck | 32 slidesEutelsat | Mergers and Acquisitions Presentation Deck | 32 slides · Eutelsat
Conference presentation Investment bank Beat · SolutionLoop · David Goliath1 hit
16
The slide uses a structured layout with a left-hand list of key metrics and a right-hand table of strategic pillars.Eutelsat | Mergers and Acquisitions Presentation Deck | 32 slides · Eutelsat
Conference presentation Investment bank Beat · SolutionLoop · David Goliath1 hit
17
The slide uses a three-column layout to represent chronological and thematic progress in the partnership.Eutelsat | Mergers and Acquisitions Presentation Deck | 32 slides · Eutelsat
Conference presentation Investment bank Beat · SolutionLoop · David Goliath1 hit
18
The slide uses visual icons (stacks of coins) to represent cash generation levels.Eutelsat | Mergers and Acquisitions Presentation Deck | 32 slides · Eutelsat
Conference presentation Investment bank Beat · SolutionLoop · David Goliath1 hit
19
The slide uses a 'plus' operator to show synergy between two technologies, followed by a breakdown of specific industry applications.Eutelsat | Mergers and Acquisitions Presentation Deck | 32 slides · Eutelsat
Conference presentation Investment bank Beat · SolutionLoop · David Goliath1 hit
16
The slide uses a bubble-map overlay to represent market size across different regions, with a specific focus on Latin American countries.Getonboard | Start Up Pitch Deck | 19 slides · Getonboard
Pitch deck Investor relations Beat · Market SizeLoop · David Goliath1 hit
19
The slide uses a grouped bar chart format to highlight clinical superiority. Includes a disclaimer about cross-trial comparisons.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · ActionLoop · David Goliath1 hit
20
The slide uses a table structure to contrast patient segments and includes a bar chart visualization for patient growth.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · ActionLoop · David Goliath1 hit
21
The slide explicitly notes that these are cross-trial comparisons and not head-to-head results.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · ActionLoop · David Goliath1 hit
22
Includes a footnote citing FDA approval precedents for similar single-arm studies.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · ActionLoop · David Goliath1 hit
21
The slide uses a bar chart to compare hematologic and cardiac response rates across different therapies.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
22
The slide uses a table structure to contrast patient segments and includes a bar chart visualization for patient growth.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
23
The slide explicitly notes that these are cross-trial comparisons and not head-to-head results.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
24
Includes a footnote citing FDA approval precedents for similar single-arm studies.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
25
Uses a visual icon-grid to represent market expansion.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
26
Includes detailed clinical trial citations in the footer.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
27
The slide uses a two-column layout to separate milestones by drug candidate.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
28
The slide uses a standard pharmaceutical pipeline table format.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
29
Includes a comparative table of clinical outcomes (ORR/CR) for NXC-201 vs. Allogeneic CAR-T and Bispecifics.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
30
The slide uses a stylized area chart to represent market segments and their respective valuations.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
31
The slide uses a red dashed box to highlight the primary efficacy metrics for comparison.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · David Goliath1 hit
32
The table uses a cross-trial comparison format. The red dashed box highlights the key clinical data rows.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · David Goliath1 hit
33
The chart uses a grouped bar structure to compare NXC-201 (green) against other therapies (blue/red/grey).Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · David Goliath1 hit
19
The slide highlights Overstock's position as a top 4 player in a large, growing market.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · VisualizationLoop · David Goliath1 hit
20
The slide uses a 2x2 matrix to highlight Overstock's unique positioning in the 'Value' quadrant.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · VisualizationLoop · David Goliath1 hit
21
Overstock | Results Presentation Deck | 34 slidesOverstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · VisualizationLoop · David Goliath1 hit
76
Uses a seesaw metaphor to illustrate the imbalance of ownership.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · SolutionLoop · David Goliath1 hit
77
Uses a treasure chest metaphor to represent value creation.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · SolutionLoop · David Goliath1 hit
78
The chart highlights an $8 billion value creation for shareholders.Sarissa Capital | Activist Presentation Deck | 109 slides · Sarissa Capital
Activist deck Activist investor Beat · SolutionLoop · David Goliath1 hit